Vivimed Labs Standalone March 2022 Net Sales at Rs 53.12 crore, up 53.19% Y-o-Y
June 07, 2022 / 09:43 IST
Reported Standalone quarterly numbers for Vivimed Labs are: Net Sales at Rs 53.12 crore in March 2022 up 53.19% from Rs. 34.68 crore in March 2021. Quarterly Net Loss at Rs. 18.60 crore in March 2022 up 40.66% from Rs. 31.35 crore in March 2021. EBITDA stands negative at Rs. 1.12 crore in March 2022 up 93.95% from Rs. 18.51 crore in March 2021. Vivimed Labs shares closed at 12.95 on June 06, 2022 (NSE) and has given -28.85% returns over the last 6 months and -56.54% over the last 12 months.
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
Story continues below Advertisement |
| Mar'22 | Dec'21 | Mar'21 | | Net Sales/Income from operations | 53.12 | 51.90 | 34.68 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 53.12 | 51.90 | 34.68 | | EXPENDITURE | | Consumption of Raw Materials | 31.12 | 38.22 | 13.28 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 1.20 | 0.49 | 4.87 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.58 | 8.07 | 9.87 | | Depreciation | 4.66 | 4.27 | 3.95 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.91 | 12.60 | 26.95 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.34 | -11.74 | -24.24 | | Other Income | 0.56 | -0.36 | 1.78 | | P/L Before Int., Excpt. Items & Tax | -5.78 | -12.10 | -22.46 | | Interest | 10.00 | 11.53 | 9.13 | | P/L Before Exceptional Items & Tax | -15.78 | -23.63 | -31.58 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.78 | -23.63 | -31.58 | | Tax | 2.82 | -- | -0.23 | | P/L After Tax from Ordinary Activities | -18.60 | -23.63 | -31.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -18.60 | -23.63 | -31.35 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.24 | -2.85 | -3.78 | | Diluted EPS | -2.18 | -2.77 | -3.67 | | EPS After Extra Ordinary | | Basic EPS | -2.24 | -2.85 | -3.78 | | Diluted EPS | -2.18 | -2.77 | -3.67 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Story continues below Advertisement
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
